T2 Biosystems Reports Granting of Inducement Awards
June 10 2019 - 7:30AM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and
commercialization of innovative medical diagnostic products for
critical unmet needs in healthcare, announced today that on June 4,
2019 it issued inducement awards to two new employees.
These awards were made under T2 Biosystems’ Inducement Award
Plan (the "Inducement Plan"), which was adopted by the company’s
Board of Directors on March 1, 2018 and amended and restated on
February 21, 2019 and provides for the granting of equity awards to
new employees of T2 Biosystems. The inducement awards consist of
options to purchase 103,000 shares of T2 Biosystems common stock
and have a ten-year term. The exercise price of the options is
$1.80, which was the per-share closing price of T2 Biosystems
common stock on the Nasdaq Capital Market on June 4, 2019. The
options vest over a four-year period, with 25% vesting on the first
anniversary of the employee’s date of hire and the remainder
vesting in equal monthly installments over the three years
thereafter. The award was approved by the independent compensation
committee of T2 Biosystems’ board of directors and was granted as
an inducement material to the new employee entering into employment
with T2 Biosystems in accordance with Nasdaq Marketplace Rule
5635(c)(4).
About T2 Biosystems:T2 Biosystems, a leader in
the development and commercialization of innovative medical
diagnostic products for critical unmet needs in healthcare, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, and T2Bacteria® Panel and are powered by the
proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems
has an active pipeline of future products, including products for
the detection of additional species and antibiotic resistance
markers of sepsis pathogens, and tests for Lyme disease.
Media Contact: Gina Kent, Vault
Communicationsgkent@vaultcommunications.com610-455-2763
Investor Contact: Zack Kubow, W2O
Groupzkubow@w2ogroup.com 415-658-6436
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024